Quantinuum publicly files Form S-1 for Nasdaq IPO under ticker symbol QNT, with J.P. Morgan and Morgan Stanley as joint lead book-running managers
On 2026-05-08, Honeywell announced that Quantinuum publicly filed a registration statement on Form S-1 with the SEC for a proposed initial public offering of Class A common stock, intending to list on the Nasdaq Global Select Market under the ticker symbol QNT. The filing carries SEC accession number 0001628280-26-032836 and CIK 0002110105 (Quantinuum Inc., Delaware-incorporated, principal place of business Broomfield, Colorado, SIC 7373). The number of shares and the price range were not specified in the filing. J.P. Morgan and Morgan Stanley are joint lead active book-running managers, with Jefferies and Evercore ISI acting as additional active book-running managers. The filing converts to public status the confidential draft registration statement Quantinuum submitted to the SEC on 2026-02-17, which Honeywell first acknowledged in its 2026-04-23 Q1 2026 earnings release and which the system logged as 2026-04-23-honeywell-q1-2026-quantinuum-ipo-confirmation-deconsolidation at score 7. Quantinuum's most recent disclosed private valuation was approximately $5B pre-money following Honeywell's announced closing of a $300M equity round in early 2024; trade-press estimates for the IPO range from $10B to $20B+ valuation but the prospectus itself does not yet contain a price range. According to Honeywell's press release, the registration has been filed but has not yet become effective; the offering will proceed only after SEC effectiveness, the publication of a price range, and a roadshow. Quantinuum has operations across the United States, United Kingdom, Germany, Japan, and Singapore, and operates the QCCD trapped-ion architecture across H1, H2, and Helios systems.
Score 8 — anchor §8.2 row 8 ("Concrete advance with near-term consequence — standards, capital, architecture, or capability"). The public S-1 unsealing converts a confidential preparatory filing into an active IPO process: SEC-published prospectus, named underwriters, named exchange and ticker, and a clear roadshow path within weeks. This is materially above the Xanadu de-SPAC trading-debut benchmark (logged at score 8 on 2026-03-27 with $302M raised at $3.1B valuation) on private-valuation magnitude and below the score-9 single-financing anchor only because the financing has not yet closed. Among pure-play quantum companies, Quantinuum is consistently rated the leader by 2-qubit gate fidelity, government-contract pipeline, and full-stack scope; its IPO at the expected magnitude would set the new public-market valuation anchor for the field and accelerates the public-quantum capital-formation cycle that Xanadu, Horizon Quantum, and Infleqtion have already opened in 2026. The presence of J.P. Morgan plus Morgan Stanley as lead book-runners (rather than smaller specialty banks) indicates institutional-investor positioning for a top-decile-by-size deep-tech IPO. The score-7 2026-04-23 confidential-confirmation precedent is updated by this event but not superseded — corrections are reserved for factual errors per spec §13, and the prior event was factually correct at time of emission. interpretation_confidence is medium because the eventual IPO size, valuation, and timing remain unannounced; source_confidence is high because the primary source is a SEC public filing.
Three downstream effects to watch. First, the IPO pricing will establish a new comparable for IonQ, Rigetti, D-Wave, and the pre-IPO PsiQuantum / Atom Computing / Pasqal pipeline; expect analyst-coverage initiations on Quantinuum within four weeks of effectiveness and trade-down comparisons against the trailing-30-day quantum public-market valuations. Second, Honeywell's planned deconsolidation of Quantinuum (telegraphed in the 2026-04-23 Q1 release as a Q2 2026 event) becomes mechanically tied to IPO effectiveness; HON.US holders should see Quantinuum reflected as a separate equity holding rather than a consolidated segment beginning in the post-IPO reporting period. Third, the QNT ticker and Nasdaq listing materially widens the pure-play public quantum universe to include the leading 2-qubit-fidelity name, which will likely shift index-construction and ETF holdings (the existing leveraged-XNDU ETF, Defiance QTUM, etc.) toward including QNT as it begins trading.